We develop, manufacture and supply market-leading wearable injectors and other proprietary drug delivery systems that our pharmaceutical customers use to enhance the provision of care, improve therapy adherence and maximize brand preference amongst patients, prescribers and payers.
Established in 2002 and NASDAQ-listed since 2010, our Company is defined by:
- The first portfolio of wearable injectors that can be prefilled using standard industry processes and supplied to patients as a fully integrated combination product ready for injection
- A strong base of pharmaceutical customers and active commercial programs
- An experienced leadership team and workforce structured to efficiently serve customer programs
- Long-term relationships with strategic partners and a network of industry leaders for production and supply
Find out more about how we can enhance and differentiate your injectable therapies under long-term partnerships.